SPL treatment decreases diabetes-induced co-immunoprecipitation (co-IP) of cldn-4 and -8. by Eduardo Molina-Jijón (4020464)

“…As shown in panel A, cldn-4 co-immunoprecipitated with cldn-8; densitometric analysis (B) shows that diabetic condition increased their interaction and SPL treatment prevents this change (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s005" target="_blank">S5 Fig</a>). Also, increased co-IP of cldn-8 with cldn-4 was found under diabetic condition and SPL decreased this interaction (C), densitometric analysis show that these changes were significant (D) (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s005" target="_blank">S5 Fig</a>). …”

PAT inhibitor decreased BMP2-induced osteoblast differentiation, which was likely mediated by Osx. by Wai Fook Leong (375133)

Decrease in Mandibular Cortical in Patients With Type 1 Diabetes Mellitus Combined with Poor Glycemic Control by Francisco Ivison Rodrigues Limeira (4629004)

MVEC microvessel formation is restricted in hydrogels exhibiting increased stiffness or decreased concentration of adhesive peptides. by Rebecca A. Scott (488956)

“…(<b>B</b>) Representative images of microvascular tubules in 7.5wt% and 15wt% hydrogels after 14 days of culture. …”

Disruption of PKA anchoring, as caused by Ht31 peptide, decreases PKA phosphorylation of downstream targets. by Rodrigo F. Oliveira (184716)

“…PhosphoThr34 DARPP-32 is averaged between 50 and 350 s and phosphoSer845 GluA1 is averaged between 50 and 300 s.…”

LRP deficiency in MΦ's results in normal IFN-γ response but decreased IL-4. by Roman Covarrubias (602292)

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Islet apoptosis increases in HFD-PBS and HFD-MSCs-NR and decreases in HFD-MSCs-R. by Patricia de Godoy Bueno (731717)

Decreased levels of PRMT1 alters BRCA1 promoter binding <i>in vivo.</i> by Irene Guendel (173419)

Decreased motor coordination deficits in <i>Cln6^nclf</i> mice. by Jeremy P. Morgan (479017)

Cigarette smoke exposure decreased the severity of pdmH1N1 infection in mice. by Yan Han (173242)

BMT did not affect pancreatic beta cell area and beta cell mass. by Saeed Katiraei (3956147)

Th2-type cellular and humoral immune responses are decreased in JH^-/- mice. by Li Yin Drake (710665)

K-RAS knock down results in decreased pERK levels <i>in vivo</i>. by Irmgard Hofmann (138529)

Aβ42 increases the level of tau in the cytosol and decreases the level of microtubule-bound tau. by Kanae Ando (1951501)

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of RAB-7 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Naloxone reverses morphine increased-caspase-3 activity, neuronal differentiation and decreased NPC expression. by Dafna Willner (605895)

“…Morphine 13 =  Morphine 13 µM; Naloxone 50 =  Naloxone 50 µM (<b>6A, 6B</b>).</p>…”

FG-2216 decreased plasma markers of cardiac injury in Nx-Ob-ZSF1 rats. by Pierre E. Signore (11218497)

Lipid content is decreased in peritoneal macrophages and foam cells derived from Plin1-/- mice. by Xiaojing Zhao (600854)

Reduced Tumor Volumes Correlate with Decreased Levels of phospho-Jak2 and phospho-STAT3. by Rebekah Baskin (622078)